Marksans Pharma Ltd announces UK MHRA approval for Fluoxetine 20mg/5ml Oral Solution

Marksans Pharma Limited has announced that UK MHRA has granted Market Authorisation to the Company's wholly owned subsidiary Relonchem Limited for Fluoxetine 20mg/5ml Oral Solution.

Related Keywords

Southport ,Sefton ,United Kingdom ,Slaidburn ,Lancashire , ,Bloomberg ,Marksans Pharma ,Relonchem Limited For Fluoxetine ,Marksans Pharma Ltd ,Marksans Pharma Limited Reuters ,Druggists Ltd ,Sons Co ,Pharma Limited ,Market Authorisation ,Relonchem Limited ,Gifford House ,Slaidburn Crescent ,Marksans Pharma Limited ,Marksanspharma ,Ine750c01026 ,Ukmhra ,Marketauthorisation ,Relonchem ,Fluxotine ,Oralsolution ,